Publications by authors named "L Saez Comet"
Article Synopsis
- The objective of the study was to map the care pathways for pregnant women with rare and complex connective tissue diseases (rcCTDs) in specialized clinical centers.
- A survey conducted by an international expert group gathered insights from 69 centers across 21 countries, revealing that most centers provided care for systemic lupus erythematosus and antiphospholipid syndrome, but less for other disorders like IgG4-related diseases.
- The study found that while a multidisciplinary team approach was common, with pre-pregnancy care offered at 96% of centers, the consistency of services and access to therapies varied widely, indicating a need for standardized care protocols to improve patient outcomes.
To assess severity markers and outcomes of patients with systemic sclerosis (SSc) with or without pulmonary arterial hypertension (PAH-SSc/non-PAH-SSc), and the impact of interstitial lung disease (ILD) on PAH-SSc. Non-PAH-SSc patients from the Spanish SSc registry and PAH-SSc patients from the Spanish PAH registry were included. A total of 364 PAH-SSc and 1589 non-PAH-SSc patients were included.
View Article and Find Full Text PDFIntroduction: The objetive of these study is to know the characteristics of COVID-19 in patients with uveitis associated with Systemic Autoimmune Disease (SAD) through telematic survey.
Material And Methods: Internal Medicine Society and Group of Systemic Autoimmune disease conducted a telematic survey of patients with SAD to learn about the characteristics of COVID-19 in this population.
Results: A total of 2,789 patients answered the survey, of which 28 had a diagnosis of uveitis associated with SAE.
Anti-Polymyositis/Scl Antibodies in Systemic Sclerosis: Clinical Associations in a Multicentric Spanish Cohort and Review of the Literature.
J Clin Rheumatol
January 2022
Objectives: To assess the clinical profile of patients with anti-polymyositis/Scl (PM/Scl) antibodies in a cohort of Spanish patients with systemic sclerosis.
Methods: From the Spanish Scleroderma Study Group database, we selected patients in whom PM/Scl antibodies had been tested. We compared demographic, clinical, laboratory, and survival data between patients with and without PM/Scl antibodies.